))
PRRT (Part Two) with Dr. Martin Auerbach
Manage episode 349899331 series 3426844
Content provided by Neuroendocrine Cancer Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Neuroendocrine Cancer Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Who is eligible for PRRT? What are the side effects? Should somatostatin analogues be continued? Can PRRT be repeated when there is disease progression? NET expert and Nuclear Medicine Physician Dr. Martin Auerbach of UCLA Health answers 10 common questions about the decision-making process of PRRT. Dr. Auerbach addresses how to manage side effects, carcinoid crisis, labs, and post-PRRT imaging. Listen now!
Be sure to listen to Episode 8: PRRT (Part One) with Administrative Nurse Lindy Gardner of UCLA Health.
For more information, visit NCF.net.
48 episodes
Share
